Personalised vaccine shows lasting promise against deadly pancreatic cancer
In the small Phase 1 trial, 16 patients with early-stage pancreatic cancer received a custom-made vaccine after surgery. After six years, nearly all patients who showed a response to the vaccine are still alive.
21 Apr 05:55 · India Today